Category: pharma & healthcare

Understanding A Global Vision Crisis: Cataracts

One of the most prevalent causes of foggy and hazy vision is cataracts. In the US, cataracts affect over 24 million people.

Electrical Signals Of The Brain To Control Movement

Brain-machine interfaces pose the opportunity to revolutionize modern regenerative medicine, but underlying research in brain signal generation, acquisition, and processing is still far from complete.

As Sexually Transmitted Infection Incidence Rises Globally, Public Health Now Emphasizes Treatment As Prevention Over Condoms

Public health increasingly focuses on treatment as prevention. While condoms were once integral to campaigns aimed at preventing STIs this is much less the case today.

Current Costs And Technology Limit Brain-Machine Interfaces

Brain-machine interfaces face significant hurdles, despite scientific advancements in the field.

How Exercise Helps Fight Alzheimer’s Disease

A silent pandemic is underway: by the year 2050, 100 million people are expected to be affected by Alzheimer’s disease. Could exercise help curb cognitive decline?

A Pomegranate A Day Keeps The Doctor Away? Researchers Rejuvenate Aging Immune Systems

Our immune system weakens as we age, leaving us more vulnerable to infections and diseases. New research has uncovered a molecule that may be able to undo the damage.

Through A New Lens: The Promise Of Virtual Reality For Enhancing Vision Therapy

Several treatment options for accommodative and vergence dysfunction are available, including lenses, prisms, and vision therapy.

Unknown Player, Untapped Potential? Using Gamma-Delta T Cells For CAR T Therapy

This article will explore the function of γδ T cells in the immune system and their potential to improve cell therapies such as CAR T therapy.

NeuraViPeR: A Ray Of Hope For The Visually Impaired

New brain implants allow blind users to see using prosthetic electrodes in their visual cortex.

The Antihistamine Benadryl Isn’t Being Removed In The U.S. From Pharmacies As An OTC Product

FDA advisory committee vote on ineffectiveness of phenylephrine as nasal decongestant doesn’t mean that the antihistamine Benadryl will be affected.